Staphylococcus Aureus Resistance to Vancomycin: A Six Years Survey, (2006-2012)

Khazaei, Sedigheh; Pourtahmaseby, Pegah; Kanani, Malek; Madani, Seyed Hamid; Malekianzadeh, Ehsan
December 2013
Medical Journal of Tabriz University of Medical Sciences & Healt;Dec2013/Jan2014, Vol. 35 Issue 5, p40
Academic Journal
Background and Objectives: According to the widespread prevalence of methicillin resistant Staphylococcus Aureus (SA). The glycopeptide vancomycine is the only uniformly effective therapy for infection. Importance of vancomycine antibiogram in treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) needs to be evaluated. This study investigated prevalence of S.A resistance to vancomycin. Materials and Methods: All samples which submitted for culture during 6years period (2006-2012) were selected and cultured on Mac-Conkey and Blood Agars, and differential media. After the diagnosis and isolation of Staphylococcus aureus, antibiogram profile of the bacteria was determined by disk-diffusion test (Kirby-Bauer) and interpreted according to CLSI standards. Results: Of 5736 samples of Staphylococcus, 3987 (%69.5) specimens were positive for S.A. 3897 (%68.1) strains of S.A were isolated from urine and 966(%16.9) were isolated from blood, and oters from wound, throat, sputum and etc. Antibiotic susceptibility results reveal that the prevalence was %4.8. Conclusion: The antimicrobial susceptibility test of SA may defer by geographic regions. In this study, the prevalence of vancomycin resistant strains is increasing gradually and due to importance of vancomycin antibiogram in treatment of MRSA, more attentions and studies are recommended.


Related Articles

  • Vancomycin.  // Reactions Weekly;May2014, Vol. 1501 Issue 1, p37 

    An abstract of the article "Transferable vancomycin resistance in a community-associated MRSA lineage," by F. Rossi and colleagues is presented.

  • Enhanced cleaning may reduce infections.  // Health Facilities Management;May2011, Vol. 24 Issue 5, p8 

    The article focuses on a study published in the "Archives of Internal Medicine" which showed that the transmission of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) can be reduced through enhanced cleaning methods in intensive care units (ICUs).

  • Vancomycin resistance among MRSA. Kumar, V. Anil // Indian Journal of Medical Research;Mar2012, Vol. 135 Issue 3, p441 

    A letter to the editor is presented in response to a study by Thati and colleagues about vancomycin resistance in methicillin resistant Staphylococcus aureus (MRSA) in South India, published in the previous issue.

  • Vancomycin resistance among MRSA. Thati, V.; Shivannavar, C. T.; Gaddad, S. M. // Indian Journal of Medical Research;Mar2012, Vol. 135 Issue 3, p441 

    A response by Thati and colleagues to a letter to the editor commenting on their study about vancomycin resistance in methicillin resistant Staphylococcus aureus (MRSA) in South India, published in the previous issue, is presented.

  • Vancomycin.  // Reactions Weekly;Feb2015, Vol. 1538 Issue 1, p234 

    The article discusses a case study of an elderly woman who developed vancomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) infection.

  • Methicillin Resistant Staphylococcus aureus: Inconsistencies in Vancomycin Susceptibility Testing Methods, Limitations and Advantages of each Method. HIMANI; AGRAWAL, CHARU; MADAN, MOLLY; PANDEY, ANITA; THAKURIA, BHASKAR // Journal of Clinical & Diagnostic Research;Oct2015, Vol. 9 Issue 10, p1 

    Background: Vancomycin may be ineffective against an increasing proportion of methicillin resistant Staphylococcus aureus (MRSA) with minimum inhibitory concentrations (MICs) well within the susceptible range. On the other hand it is common knowledge that determination of vancomycin MICs is...

  • Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. ... Zhanel, George G.; Rossnagel, Emma; Nichol, Kim; Cox, Lauren; Karlowsky, James A.; Zelenitsky, Sheryl; Noreddin, Ayman M.; Hoban, Daryl J. // Journal of Antimicrobial Chemotherapy (JAC);Jun2011, Vol. 66 Issue 6, p1301 

    Background This study assessed the pharmacodynamics of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA), heteroresistant (h) vancomycin-intermediate S. aureus (hVISA), VISA and vancomycin-resistant S. aureus (VRSA) using an in vitro model. Methods Two...

  • Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates. Falcón, Rocío; Madrid, Silvia; Tormo, Nuria; Casañ, Cristina; Albert, Eliseo; Gimeno, Concepción; Navarro, David // Clinical Infectious Diseases;11/1/2015, Vol. 61 Issue 9, p1490 

    The article discusses the intra- and interinstitutional evaluation of an Etest for vancomycin minimum inhibitory concentration (MIC) measurement in Staphylococcus aureus blood isolates. Topics include clinical outcome of patients with left-sided endocarditis due to methicillin-susceptible...

  • Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates in Rayalaseema region Andhra Pradesh, South India. Chandra Mohan, Reddy. P.; Venu Babu Thati; Shivannavar, C. T.; Gaddad, Subhash Chandra M. // World Journal of Science & Technology;2012, Vol. 2 Issue 1, p6 

    Multidrug resistant MRSA have become a major cause of nosocomial and community acquired infections. The glycopeptide, vancomycin, has been proposed as the drug of choice for treating such infections. However, during the recent years increasing trend in vancomycin resistance is being reported....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics